Drug Price Compare
drug_price_comparePut the two US drug price benchmarks side by side for one drug — what a pharmacy pays to acquire it (NADAC, weekly) against what Medicare Part B pays a provider for it (ASP limit, quarterly). Use to see the spread between acquisition cost and reimbursement, or to check whether a drug is a retail or a clinic-administered product at all. States the vintage of each number and warns when they are measured months apart, because the ASP limit in force is derived from ASP data two quarters earlier. Returns whichever benchmarks exist — many drugs legitimately have only one. Keyless.
Input Schema
| Name | Required | Description | Default |
|---|---|---|---|
| ndc | No | Optional NDC to pin the NADAC side to one product. | |
| drug | Yes | Drug name, e.g. "pembrolizumab", "atorvastatin", "rituximab". |